Stamford, CT -- (SBWIRE) -- 01/27/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Advanced Micro Devices, Inc. (NYSE:AMD), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), Generex Biotechnology Corporation (OTCMKTS:GNBT), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA).
Advanced Micro Devices, Inc. (NYSE:AMD) opened its last trade at the price of $3.60. Its closing price was $3.47 after losing -4.14% for the day. The company traded with the total volume of 48.35 million shares, while its average trading volume remained 27.83 million shares. The beta of this stock stands at 2.21. Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. It operates in two segments, Computing Solutions and Graphics. The company designs, develops, and sells microprocessor products, such as central processing units (CPU) and accelerated processing units (APU) for servers, desktop PCs, and mobile devices.
Has AMD Found The Bottom and Ready To Move Up? Find Out Here
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) percentage change surged 13.90% to close at $2.13 with the total traded volume of 17.93 million shares, along with average volume of 3.56 million shares. The 52 week range of the stock remained $0.56 - $6.03, while its day lowest price was $1.82. The share price hit the day highest price of $2.98. Provectus Biopharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications.
Will PVCT Continue To Move Higher? Find Out Here
Generex Biotechnology Corporation (OTCMKTS:GNBT) traded on volume of 24.43 million shares in the last session against average volume of 6.77 million shares. The company started its trading session with the price of $0.04 and closed at $0.0513 by scoring +16.59%. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Why Should Investors Buy GNBT After The Recent Gain? Just Go Here and Find Out
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) started its last trading session with the price of $7.37 and closed at $8.99 by scoring 19.55%. The stock traded with total volume of 134.48 million shares, while the average trading volume remained 34.59 million shares. The beta value of this stock stands at 0.83. Day range for the stock was $7.35 - $9.83. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors.
For How Long ARIA will Fight for Profitability? Read This Trend Analysis report
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)